301. Evidence based management of Bell's palsy
- Author
-
Luke Cascarini, Darryl Coombes, Peter A. Brennan, Daryl Godden, Cyrus Kerawala, and James McCaul
- Subjects
Weakness ,Pediatrics ,medicine.medical_specialty ,Population ,Remission, Spontaneous ,Evidence-Based Dentistry ,Bell's palsy ,medicine ,Bell Palsy ,Humans ,education ,education.field_of_study ,Palsy ,Evidence-Based Medicine ,business.industry ,Evidence-based management ,Recovery of Function ,medicine.disease ,Facial nerve ,Facial paralysis ,Surgery ,stomatognathic diseases ,Facial Nerve ,Otorhinolaryngology ,Lifetime risk ,Oral Surgery ,medicine.symptom ,business - Abstract
Bell’s palsy (idiopathic facial paralysis) is caused by the acute onset of lower motor neurone weakness of the facial nerve with no detectable cause. With a lifetime risk of 1 in 60 and an annual incidence of 11–40/100,000 population, the condition resolves completely in around 71% of untreated cases. In the remainder facial nerve function will be impaired in the long term. We summarise current published articles regarding early management strategies to maximise recovery of facial nerve function and minimise long-term sequelae in the condition. © 2014 Published by Elsevier Ltd. on behalf of The British Association of Oral and Maxillofacial Surgeons.
- Published
- 2013